{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:00:00Z","timestamp":1787263200939,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.humpath.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T11:28:43Z","timestamp":1566214123000},"page":"67-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva"],"prefix":"10.1016","volume":"92","author":[{"given":"Deyin","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inji","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Cheang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Novo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max A.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chea","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Fu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzyy-Choou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.08.003_bb0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2019.08.003_bb0010","series-title":"WHO classification of tumors of female reproductive organs","author":"Kurman","year":"2014"},{"key":"10.1016\/j.humpath.2019.08.003_bb0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.03.003","article-title":"Vulvar cancer: two pathways with different localization and prognosis","volume":"149","author":"Hinten","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0020","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.31006","article-title":"Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: a study of 1,594 cases","volume":"141","author":"Rakislova","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2019.08.003_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0029-7844(95)00351-7","article-title":"Heterogeneous etiology of squamous carcinoma of the vulva","volume":"87","author":"Trimble","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0030","first-page":"1655","article-title":"Carcinoma of the vulva: HPV and p53 mutations","volume":"9","author":"Lee","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2019.08.003_bb0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2009.179","article-title":"Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma","volume":"23","author":"Pinto","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0040","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1038\/sj.bjc.6601444","article-title":"TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva","volume":"89","author":"Rolfe","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2019.08.003_bb0045","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1158\/1078-0432.CCR-16-3230","article-title":"Vulvar squamous cell carcinoma (VSCC) as two diseases: HPV status identifies distinct mutational profiles including oncogenic fibroblast growth factor receptor 3","volume":"23","author":"Weberpals","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.003_bb0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2017.05.011","article-title":"Identification of molecular targets in vulvar cancers","volume":"146","author":"Palisoul","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2018.06.026","article-title":"Somatic mutation profiling of vulvar cancer: exploring therapeutic targets","volume":"150","author":"Zieba","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/IGC.0b013e31823eed4c","article-title":"Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment","volume":"22","author":"Woelber","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.humpath.2019.08.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.02.007","article-title":"Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: results from the AGO-CaRE-1 study","author":"Polterauer","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/gyno.1995.1151","article-title":"The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients","volume":"57","author":"Burger","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/PAS.0000000000000565","article-title":"Lower female genital tract tumors with adenoid cystic differentiation: P16 expression and high-risk HPV detection","volume":"40","author":"Xing","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0080","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/his.13723","article-title":"PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy","volume":"74","author":"Chinn","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2019.08.003_bb0085","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: molecular characterization by next-generation sequencing and histopathological comparison with tall cell papillary carcinoma of thyroid","volume":"1066896918800779","author":"Zhong","year":"2018","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","article-title":"Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix","volume":"42","author":"Xing","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2019.08.003_bb0100","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.28288","article-title":"Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2019.08.003_bb0105","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1158\/1078-0432.CCR-16-0323","article-title":"Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number alterations, PIK3CA mutation, and pathway signatures","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.003_bb0110","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","article-title":"New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway","volume":"96","author":"Cantley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2019.08.003_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41379-018-0141-4","article-title":"Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma","volume":"32","author":"Regauer","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2014.07.094","article-title":"CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma","volume":"135","author":"Trietsch","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0125","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/annonc\/mdw242","article-title":"The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy","volume":"27","author":"Clancy","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.4770","article-title":"Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H)","volume":"240","author":"Li","year":"2016","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1999.tb09414.x","article-title":"BAP1, a candidate tumor suppressor protein that interacts with BRCA1","volume":"886","author":"Jensen","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.humpath.2019.08.003_bb0140","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-17-1573","article-title":"BAP1 is a novel target in HPV-negative head and neck Cancer","volume":"24","author":"Liu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.003_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajhg.2015.02.017","article-title":"Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma","volume":"96","author":"Zhang","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.humpath.2019.08.003_bb0150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/cas.12722","article-title":"Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma","volume":"106","author":"Mori","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2019.08.003_bb0155","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4161\/cc.4.8.1869","article-title":"Modeling resistance to pathway-targeted therapy in ovarian cancer","volume":"4","author":"Xing","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2019.08.003_bb0160","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1073\/pnas.0502256102","article-title":"A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance","volume":"102","author":"Xing","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2019.08.003_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellsig.2013.09.021","article-title":"New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of gamma-secretase inhibitor resistant T-cell acute lymphoblastic leukemia","volume":"26","author":"Hales","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.humpath.2019.08.003_bb0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1593\/neo.04586","article-title":"Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer","volume":"7","author":"Bashyam","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.humpath.2019.08.003_bb0175","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1158\/0008-5472.CAN-08-2929","article-title":"MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression","volume":"69","author":"Ma","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.003_bb0180","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1038\/onc.2010.300","article-title":"Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency","volume":"29","author":"Cheng","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2019.08.003_bb0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00428-012-1268-1","article-title":"BIRC2 amplification in squamous cell carcinomas of the uterine cervix","volume":"461","author":"Choschzick","year":"2012","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2019.08.003_bb0190","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2019.08.003_bb0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamaoncol.2015.6326","article-title":"Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva","volume":"2","author":"Howitt","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0200","doi-asserted-by":"crossref","first-page":"92890","DOI":"10.18632\/oncotarget.21641","article-title":"Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology","volume":"8","author":"Hecking","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2019.08.003_bb0205","doi-asserted-by":"crossref","unstructured":"Burgess EF, Livasy C, Hartman A, et al. Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions. Urol Oncol 2019;37:299 e19- e25.","DOI":"10.1016\/j.urolonc.2019.01.002"},{"key":"10.1016\/j.humpath.2019.08.003_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ajcp\/aqy141","article-title":"Association of PD-L1, PD-L2, and immune response markers in matched renal clear cell carcinoma primary and metastatic tissue specimens","volume":"151","author":"Basu","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356146","article-title":"Temporal and spatial heterogeneity of programmed cell death 1-ligand 1 expression in malignant mesothelioma","volume":"6","author":"Terra","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humpath.2019.08.003_bb0220","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/annonc\/mdw289","article-title":"Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer","volume":"27","author":"Mansfield","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2019.08.003_bb0225","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/2326-6066.CIR-15-0043","article-title":"Differential expression of PD-L1 between primary and metastatic sites in clear-cell renal cell carcinoma","volume":"3","author":"Callea","year":"2015","journal-title":"Cancer Immunol Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:36:08Z","timestamp":1758645368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719301364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":45,"alternative-id":["S0046817719301364"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.08.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}